Differentiated thyroid cancer: management of patients with radioiodine nonresponsive disease
{{output}}
Differentiated thyroid carcinoma (papillary and follicular) has a favorable prognosis with an 85% 10-year survival. The patients that recur often require surgery and further radioactive iodine to render them disease-free. Five percent of thyroid cancer patient... ...
